31 March 2021 in Liver Transplantation
1 May 2022 in Journal of Clinical and Experimental Hepatology
IKIlankumaran Kaliamoorthy
+5
5 March 2020 in World Journal of Surgery
9 July 2024 in American Journal of Transplantation
15 May 2015 in Liver Transplantation
CVChandrasekaran Venkataraman
Chandrasekaran Venkataraman
INTRODUCTION Primary Hyperoxaluria Type 1 (PH1) is ideally treated by liver-kidney transplantation once renal function has deteriorated beyond a certain point. Deceased donor synchronous combined liver-kidney transplantation is most commonly used to treat such patients. However in the living donor setting, the familial nature of this disease, need for two organs and the variable intensity of disease in the recipient challenge the principle of double equipoise that forms the basis of living donor transplantation. METHODS Patients' diagnosed with PH 1 and renal failure between October 2009 and February 2014 were treated with aggressive preoperative dialysis and liver-kidney transplantation. Dialysis was continued postoperatively for 72 hours. Patients were chosen for deceased donor combined liver-kidney transplantation, living donor synchronous liver kidney transplantation or living donor sequential liver-kidney transplantation according to donor availability and perceived systemic oxalate load. RESULTS Seven patients with PH 1 underwent liver kidney transplantation - either synchronously (2 from deceased donors, 3 from living donors) or sequentially (2 from living donors). Sibling donors underwent genetic testing to exclude disease prior to donation. Six of 7 patients had evidence of systemic oxalosis (Cardiomyopathy 6, Osteopathy 3, Retinopathy 1). One patient who underwent synchronous transplantation required retransplantation due to oxalate deposition in the transplanted kidney. Re-exploration for bleeding was necessary in 3 of 7 recipients. There were no donor complications. CONCLUSIONS Sequential LKT matches the greatest likelihood of successful outcome for the recipient with least risk to the donor, particularly in patients with clinical evidence of severe systemic oxalosis. Intensive perioperative hemodialysis is necessary to prepare these patients for surgery and protect the renal allograft from oxalate deposition when synchronous Liver-Kidney Transplantation is performed. This article is protected by copyright. All rights reserved.
1 January 2022 in Journal of Clinical and Experimental Hepatology